In vivo administration of recombinant granulocyte colony stimulating factor corrects acquired neutrophil function deficiency association with chronic graft-versus-host disease

Br J Haematol. 1993 Jan;83(1):169-70. doi: 10.1111/j.1365-2141.1993.tb04649.x.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Bone Marrow Transplantation
  • Cell Adhesion / drug effects
  • Chemotaxis, Leukocyte / drug effects
  • Female
  • Graft vs Host Disease / complications*
  • Granulocyte Colony-Stimulating Factor / therapeutic use*
  • Humans
  • Neutrophils / drug effects*
  • Nitroblue Tetrazolium / analysis
  • Phagocytosis / drug effects
  • Recombinant Proteins / therapeutic use

Substances

  • Recombinant Proteins
  • Granulocyte Colony-Stimulating Factor
  • Nitroblue Tetrazolium